About Arrowhead Research Corporation
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Market Cap
$1.73B
Employees
525
Listed Since
January 6, 1997
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.arrowheadpharma.comPhone
626-696-4702
Headquarters
177 E COLORADO BLVD
PASADENA, CA 91105
CIK
0000879407